Abstract
Guido Bastiaens and colleagues describe barriers to achieving scale-up and appropriate use of rapid diagnostic tests and artemisinin-based combination therapy for malaria in sub-Saharan Africa.
Please see later in the article for the Editors' Summary
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Africa South of the Sahara
-
Antimalarials / therapeutic use*
-
Artemisinins / therapeutic use*
-
Delivery of Health Care
-
Diagnostic Tests, Routine / statistics & numerical data*
-
Drug Combinations
-
Health Knowledge, Attitudes, Practice
-
Health Policy
-
Humans
-
Malaria / diagnosis*
-
Malaria / drug therapy*
-
Malaria / parasitology
Substances
-
Antimalarials
-
Artemisinins
-
Drug Combinations
-
artemisinin
Grants and funding
Guido Bastiaens is a PhD student employed at the Radboud University Medical Center. Teun Bousema is supported through a grant from the Bill & Melinda Gates Foundation, 51991. Toby Leslie is supported by the ACT Consortium with a grant from the Bill & Melinda Gates Foundation through the London School of Hygiene & Tropical Medicine, 39640. The funders had no role in design, analysis, decision to publish, or preparation of the manuscript.